Who is sponsoring NCT01838460?

NCT01838460 is sponsored by Contract Research Organization el AB.

What drugs are being tested in NCT01838460?

Interventions in NCT01838460: sublingual nicotine tablets, Smokeless tobacco.

What condition does NCT01838460 study?

NCT01838460 studies Smoking Cessation.

Is NCT01838460 still recruiting?

NCT01838460 is currently completed. Last updated 19 April 2013.

Last reviewed 2013-04-19 · How we verify

NCT01838460

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Elevated Dose of Sublingual Nicotine Tablets Compared With Swedish Snus. Nicotine Pharmacokinetics and Subjective Effects of Single Doses.

Completed Phase 1/Phase 2 Last updated 19 April 2013

What this trial tests

Phase 1/Phase 2 trial testing sublingual nicotine tablets in Smoking Cessation in 16 participants. Completed in 1 February 2013.

Timeline

1 May 2012

Primary endpoint
1 August 2012

1 February 2013

Quick facts

Lead sponsor	Contract Research Organization el AB
Phase	Phase 1/Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	1 May 2012
Primary completion	1 August 2012
Estimated completion	1 February 2013
Sites	1 location across Sweden

Drugs / interventions tested

sublingual nicotine tablets — full drug profile →
Smokeless tobacco — full drug profile →

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

Contract Research Organization el AB — full company profile →

Who can join

Adults 18 to 50, any sex, with Smoking Cessation. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

AUCinf
Time frame: 6 hours

Sponsor's own description

To compare each subject's AUCinf, after administration of one single dose of 6 mg of Nicorette sublingual nicotine tablets ( three 2mg tablets) to that of one single 1 g dose of SS containing 16 mg nicotine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01838460 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Contract Research Organization el AB
Last refreshed: 19 April 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01838460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing